Literature DB >> 23196362

Prevalence of and risk factors for biliary carriage of bacteria showing worrisome and unexpected resistance traits.

E Maseda1, G Maggi, R Gomez-Gil, G Ruiz, R Madero, A Garcia-Perea, L Aguilar, F Gilsanz, J Rodriguez-Baño.   

Abstract

Data on biliary carriage of bacteria and, specifically, of bacteria with worrisome and unexpected resistance traits (URB) are lacking. A prospective study (April 2010 to December 2011) was performed that included all patients admitted for <48 h for elective laparoscopic cholecystectomy in a Spanish hospital. Bile samples were cultured and epidemiological/clinical data recorded. Logistic regression models (stepwise) were performed using bactobilia or bactobilia by URB as dependent variables. Models (P < 0.001) showing the highest R(2) values were considered. A total of 198 patients (40.4% males; age, 55.3 ± 17.3 years) were included. Bactobilia was found in 44 of them (22.2%). The presence of bactobilia was associated (R(2) Cox, 0.30) with previous biliary endoscopic retrograde cholangiopancreatography (ERCP) (odds ratio [OR], 8.95; 95% confidence interval [CI], 2.96 to 27.06; P < 0.001), previous admission (OR, 2.82; 95% CI, 1.10 to 7.24; P = 0.031), and age (OR, 1.09 per year; 95% CI, 1.05 to 1.12; P < 0.001). Ten out of the 44 (22.7%) patients with bactobilia carried URB: 1 Escherichia coli isolate (CTX-M), 1 Klebsiella pneumoniae isolate (OXA-48), 3 high-level gentamicin-resistant enterococci, 1 vancomycin-resistant Enterococcus isolate, 3 Enterobacter cloacae strains, and 1 imipenem-resistant Pseudomonas aeruginosa strain. Bactobilia by URB (versus those by non-URB) was only associated (R(2) Cox, 0.19) with previous ERCP (OR, 11.11; 95% CI, 1.98 to 62.47; P = 0.006). For analyses of patients with bactobilia by URB versus the remaining patients, previous ERCP (OR, 35.284; 95% CI, 5.320 to 234.016; P < 0.001), previous intake of antibiotics (OR, 7.200; 95% CI, 0.962 to 53.906; P = 0.050), and age (OR, 1.113 per year of age; 95% CI, 1.028 to 1.206; P = 0.009) were associated with bactobilia by URB (R(2) Cox, 0.19; P < 0.001). Previous antibiotic exposure (in addition to age and previous ERCP) was a risk driver for bactobilia by URB. This may have implications in prophylactic/therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196362      PMCID: PMC3553897          DOI: 10.1128/JCM.02469-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  How does infected bile affect the postoperative course of patients undergoing laparoscopic cholecystectomy?

Authors:  R Gold-Deutch; R Mashiach; I Boldur; M Ferszt; M Negri; Z Halperin; G Lin; J Sackier; A Halevy
Journal:  Am J Surg       Date:  1996-09       Impact factor: 2.565

2.  [Bacteriologic findings as a prognostic factor in the course of acute cholecystitis].

Authors:  R Calpena Rico; J R Sánchez Llinares; F Candela Polo; M T Pérez Vázquez; J L Vázquez Rojas; M Diego Estévez; A Compañ Rosique; J Medrano Heredia
Journal:  Rev Esp Enferm Apar Dig       Date:  1989-11

Review 3.  Incidence and significance of intraperitoneal aerobic and anaerobic bacteria.

Authors:  C E Nord
Journal:  Clin Ther       Date:  1990       Impact factor: 3.393

4.  Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp.

Authors:  W Michael Dunne; Daniel J Hardin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  Profile and predictors of bile infection in patients undergoing laparoscopic cholecystectomy.

Authors:  Azmi M Mahafzah; Salam S Daradkeh
Journal:  Saudi Med J       Date:  2009-08       Impact factor: 1.484

Review 6.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.

Authors:  Hajo Grundmann; Marta Aires-de-Sousa; John Boyce; Edine Tiemersma
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  Microbiology of gallbladder bile in uncomplicated symptomatic cholelithiasis.

Authors:  Vasitha Abeysuriya; Kemal Ismil Deen; Tamara Wijesuriya; Sujatha Senadera Salgado
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2008-12

9.  Bacteriological investigation of bile in patients with cholelithiasis.

Authors:  H Ohdan; H Oshiro; Y Yamamoto; I Tanaka; K Inagaki; K Sumimoto; T Hinoi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 10.  Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.

Authors:  R Leclercq
Journal:  Clin Microbiol Infect       Date:  2009-03       Impact factor: 8.067

View more
  3 in total

Review 1.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  Microorganisms isolated from the bile of the patients who have undergone cholecystectomy and their antibiotic resistance pattern: multicenter prospective study.

Authors:  Derya Ozturk-Engin; Canan Agalar; Yasemin Cag; Fatma Kesmez Can; Ilker Inanc Balkan; Oguz Karabay; Seniha Senbayrak; Busra Meral Çetinkaya; Mehmet Timuçin Aydın; Kadir Tomas; Esra Disci; Ali Surmelioglu; Orhan Alimoglu; Ozgur Ekinci; Emrah Akın; Mehmet Köroglu; Mehmet Velidedeoglu; Handan Ankaralı; Esra Kocoglu; Mirkhaliq Javadov; Berrin Papilla-Kundaktepe; Naz Oguzoglu; Erkan Ozmen; Ramazan Donmez; Ertunç Mega; Sebahat Aksaray; Fatih Agalar
Journal:  Int Microbiol       Date:  2022-07-02       Impact factor: 3.097

Review 3.  Treatment of Malignant Bile Duct Obstruction: What the Interventional Radiologist Needs to Know.

Authors:  Juan C Camacho; Lynn A Brody; Anne M Covey
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.